RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
12.02
-0.03 (-0.25%)
Nov 29, 2022 4:00 PM EDT - Market closed
-0.25%
Market Cap 334.05M
Revenue (ttm) 41.34M
Net Income (ttm) -66.88M
Shares Out 27.67M
EPS (ttm) -3.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 28,447
Open 11.99
Previous Close 12.05
Day's Range 11.55 - 12.28
52-Week Range 8.8 - 16.99
Beta n/a
Analysts Buy
Price Target 20.66 (+71.9%)
Earnings Date Nov 7, 2022

About RXST

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction ... [Read more]

Industry Medical Devices
IPO Date Jul 30, 2021
Employees 221
Stock Exchange NASDAQ
Ticker Symbol RXST
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for RXST stock is "Buy." The 12-month stock price forecast is 20.66, which is an increase of 71.88% from the latest price.

Price Target
$20.66
(71.88% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Wall Street Analysts Predict a 45% Upside in RxSight, Inc. (RXST): Here's What You Should Know

The mean of analysts' price targets for RxSight, Inc. (RXST) points to a 45% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys...

1 week ago - Zacks Investment Research

RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) delivered earnings and revenue surprises of 12.86% and 19.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

RxSight, Inc. (RXST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

RxSight, Inc. (RXST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 weeks ago - Zacks Investment Research

RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022

ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

1 month ago - GlobeNewsWire

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

ALISO VIEJO, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

3 months ago - GlobeNewsWire

RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) delivered earnings and revenue surprises of 26.47% and 0.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, toda...

3 months ago - GlobeNewsWire

RxSight, Inc. Reports Second Quarter 2022 Financial Results

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, toda...

3 months ago - GlobeNewsWire

RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022

ALISO VIEJO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, toda...

4 months ago - GlobeNewsWire

RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, to...

7 months ago - GlobeNewsWire

Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and...

ALISO VIEJO, Calif. , April 19, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, t...

7 months ago - GlobeNewsWire

RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, to...

8 months ago - GlobeNewsWire

RxSight, Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results

ALISO VIEJO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today...

8 months ago - GlobeNewsWire

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 8, 2022

ALISO VIEJO, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, toda...

9 months ago - GlobeNewsWire

RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference

ALISO VIEJO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans...

9 months ago - GlobeNewsWire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

ALISO VIEJO, Calif., Jan. 09, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

10 months ago - GlobeNewsWire

RxSight, Inc. Appoints Dr. Tamara R. Fountain, M.D.

ALISO VIEJO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

10 months ago - GlobeNewsWire

RxSight to Present at the J.P. Morgan Healthcare Conference

ALISO VIEJO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

11 months ago - GlobeNewsWire

RxSight to Participate in the Ophthalmology Day at BTIG

ALISO VIEJO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

1 year ago - GlobeNewsWire

RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021

ALISO VIEJO, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the third quarter of 2021 after the ...

1 year ago - GlobeNewsWire

RxSight Reports Second Quarter 2021 Financial Results

ALISO VIEJO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported finan...

1 year ago - GlobeNewsWire

RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021

ALISO VIEJO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company, today announced an updated date for reporting second quarter 2021 financial re...

1 year ago - GlobeNewsWire

RxSight to Participate in the Wells Fargo Healthcare Conference

ALISO VIEJO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, today announced plans to participate in the upcoming virtual Wells Fargo Health...

1 year ago - GlobeNewsWire

RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021

ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the...

1 year ago - GlobeNewsWire

Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), an early stage platform technology company that promotes oral dosing with its RaniPill, and RxSight, Inc. (NASDAQ:RXST), an ophthalmology-focused MedTech ...

Other symbols: RANI
1 year ago - Benzinga